Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.
Alpha Tau MedicalFTAC Parnassus Acquisition

Alpha Tau Medical vs FTAC Parnassus Acquisition

On this page, Alpha Tau Medical Ltd-CL A and FTAC PARNASSUS ACQUISITION-A are compared to illuminate differences in business models, financial performance, and market context in a neutral, accessible ...

Investment Analysis

Pros

  • Alpha Tau Medical presents innovative oncology therapeutics through its proprietary Alpha DaRT technology targeting solid tumors.
  • The company has strong liquidity metrics with a quick ratio of 5.49 and current ratio of 5.81.
  • Recent financing secured $26 million to fund a pivotal clinical trial, supporting continued clinical development efforts.

Considerations

  • Alpha Tau Medical is a clinical-stage company with ongoing trials, thus currently generating no revenue and negative earnings.
  • It suffers from significant losses, demonstrated by negative return on assets (−35.56%) and equity (−47.53%).
  • The company’s market capitalization is relatively small (~$287 million), implying higher risk and potentially limited market presence.

Pros

  • FTAC Parnassus Acquisition Corp has approximately $347 million market capitalization, providing substantial firepower for acquisitions.
  • The company has profitable recent financials, recording a $5 million profit after tax recently despite being a blank-check acquisition vehicle.
  • Management appears stable and experienced, with CEO Ryan M. Gilbert leading the firm since its founding in 2020.

Considerations

  • FTAC Parnassus Acquisition Corp currently operates as a blank-check company with no actual operating business or revenues.
  • Its investment focus on technology and financial services technology involves high competition and execution risk for successful mergers.
  • The stock price has little volatility or trading volume, potentially indicating limited liquidity and investor interest.

Buy DRTS or FTPA in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

Alpha Tau MedicalCitizens & Northern

Alpha Tau Medical vs Citizens & Northern

Alpha Tau Medical vs Citizens & Northern

Alpha Tau MedicalDiamond Hill

Alpha Tau Medical vs Diamond Hill

Alpha Tau Medical vs Diamond Hill

Alpha Tau MedicalMBIA

Alpha Tau Medical vs MBIA

Alpha Tau Medical vs MBIA

Frequently asked questions